HUMAN ALBUMIN SOLUTION

DRUG3 trials

Sponsors

Fakultni Nemocnice Hradec Kralove, Centre Hospitalier Universitaire De Rennes, Aalborg University Hospital

Conditions

Fertility DisordersHabitual AbortionIschemic strokeLiver transplantationMiscarriageRecurrent Pregnancy Loss

Phase 2

Intravenous Immunoglobulin and Prednisolone for RPL After ART.

CompletedNCT04701034

Aalborg University HospitalFertility Disorders, Habitual Abortion, Miscarriage +1

Start: 2021-01-28End: 2024-04-18Updated: 2025-11-24

Modulation of the Extent of Ischemic Brain Damage by Protecting the Endothelial Glycocalyx with Low-Dose Albumin Administration (MOZEG)

Not yet recruitingCTIS2023-509261-20-00

Fakultni Nemocnice Hradec KraloveIschemic stroke

Target: 100Updated: 2025-03-26

Phase 4

HALT : Influence of Human Albumin supplementation on kidney dysfunction after Liver Transplantation

RecruitingCTIS2024-514804-14-00

Centre Hospitalier Universitaire De RennesLiver transplantation

Start: 2025-03-26Target: 400Updated: 2025-12-01

Related Papers

Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a randomised, double-blind, placebo-controlled trial.

2025-11-19

O-032 Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss undergoing assisted reproductive technology treatment: a randomized, double-blinded, placebo-controlled trial

Human Reproduction2024-07-01

Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial

BMJ Open2022-09-017 citations